Mr. Callen is an integral part of the Karli Center where he works closely with the executive team to seamlessly integrate the Greyledge bio-data model into the Karli Center's medical records platform. His skill and competence in data analytics and software architecture transformed both companies' use of software as a system enabling Machine Learning and using Artificial Intelligence to advance the field of Regenerative Medicine. Through the rigorous application of data science, he links critical pieces of biological data to reported patient outcomes thereby helping Greyledge move toward specific and customized regenerative, biologic treatments -- the right dose for you, which is unique to Greyledge's processing technologies.